Acurx Pharmaceuticals Inc
ACXP
NASDAQ
Biotechnology
$1.40
USD
-0.09 (-5.74%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $6.36M
Volume 606.7K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
MTVA | MetaVia Inc | $9.45M | - | - | - | |
BIVI | BioVie Inc | $8.30M | - | - | - | |
LIMN | Liminatus Pharma Inc | $7.86M | - | - | - | |
ALZN | Alzamend Neuro Inc | $7.00M | - | - | - | |
IMNN | Imunon Inc | $6.80M | - | - | - | |
ACXP | Acurx Pharmaceuticals Inc | $6.58M | - | - | - | |
FBLG | Fibrobiologics Inc | $6.53M | - | - | - | |
AQB | AquaBounty Technologies Inc | $6.38M | - | -47.0% | - | |
APVO | Aptevo Therapeutics Inc | $6.13M | - | - | - | |
PMCB | PharmaCyte Biotech Inc | $5.86M | - | - | - | |
CELZ | Creative Medical Technology Holdings Inc | $5.69M | - | -78.6% | - |
Top Peer by Growth
Bolt Biotherapeutics Inc
+78.6% YoY Revenue
Best 1-Year Return
Xenetic Biosciences Inc
+10.0% Return